Shanghai Haohai Biological Technology Co., Ltd. Class H(HK:6826)
HK$15.78+0.26 (+1.68%)
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H financials statements
HK$15.78
At close:+0.26 (+1.68%)
Want to see HK:6826 full AI Analyst Report?
Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Ratios
0 Followers
Shanghai Haohai Biological Technology Co., Ltd. Class H Ratios
HK:6826's free cash flow for Q3 2026 was ¥73.03M. For the 2026 fiscal year, HK:6826's free cash flow was decreased by ¥-16.97M and operating cash flow was ¥90.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.79 | 4.22 | 5.24 | 6.91 | 7.62 |
| Quick Ratio | 3.21 | 3.66 | 4.50 | 5.96 | 6.89 |
| Cash Ratio | 2.68 | 3.04 | 3.83 | 4.97 | 5.95 |
| Solvency Ratio | 0.40 | 0.50 | 0.56 | 0.39 | 0.58 |
| Operating Cash Flow Ratio | 0.69 | 0.75 | 0.89 | 0.45 | 0.70 |
| Short-Term Operating Cash Flow Coverage | 2.00 | 2.26 | 3.23 | 17.77 | 7.00 |
| Net Current Asset Value | ¥ 2.35B | ¥ 2.45B | ¥ 2.66B | ¥ 2.54B | ¥ 2.82B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.06 | 0.06 | 0.02 | 0.02 |
| Debt-to-Equity Ratio | 0.07 | 0.08 | 0.07 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.07 | 0.07 | 0.07 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.02 | 0.03 | 0.01 | 0.00 |
| Financial Leverage Ratio | 1.24 | 1.28 | 1.26 | 1.25 | 1.22 |
| Debt Service Coverage Ratio | 1.25 | 1.50 | 3.03 | 19.50 | 9.56 |
| Interest Coverage Ratio | 12.05 | 19.26 | 60.09 | 20.49 | 35.47 |
| Debt to Market Cap | 0.07 | 0.07 | 0.08 | 0.01 | 0.01 |
| Interest Debt Per Share | 1.79 | 2.00 | 2.43 | 0.73 | 0.63 |
| Net Debt to EBITDA | -4.59 | -3.97 | -3.27 | -5.41 | -5.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 69.06% | 69.74% | 70.34% | 68.79% | 71.98% |
| EBIT Margin | 9.78% | 13.88% | 19.57% | 11.57% | 22.15% |
| EBITDA Margin | 18.23% | 20.49% | 27.08% | 21.28% | 31.45% |
| Operating Profit Margin | 9.06% | 12.98% | 16.64% | 7.41% | 10.06% |
| Pretax Profit Margin | 9.78% | 17.40% | 19.29% | 11.21% | 21.86% |
| Net Profit Margin | 10.00% | 15.69% | 15.79% | 8.58% | 20.13% |
| Continuous Operations Profit Margin | 8.30% | 14.04% | 15.65% | 9.05% | 19.84% |
| Net Income Per EBT | 102.20% | 90.20% | 81.87% | 76.56% | 92.05% |
| EBT Per EBIT | 107.95% | 133.98% | 115.94% | 151.29% | 217.38% |
| Return on Assets (ROA) | 3.64% | 5.90% | 5.86% | 2.62% | 5.07% |
| Return on Equity (ROE) | 4.51% | 7.54% | 7.36% | 3.27% | 6.16% |
| Return on Capital Employed (ROCE) | 3.82% | 5.56% | 6.86% | 2.44% | 2.72% |
| Return on Invested Capital (ROIC) | 3.15% | 4.28% | 5.38% | 1.96% | 2.45% |
| Return on Tangible Assets | 4.04% | 7.02% | 6.98% | 3.17% | 6.11% |
| Earnings Yield | 4.80% | 7.21% | 9.90% | 4.47% | 6.67% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.88 | 7.26 | 7.82 | 5.42 | 4.66 |
| Payables Turnover | 11.10 | 13.06 | 14.18 | 12.04 | 10.60 |
| Inventory Turnover | 1.45 | 1.65 | 1.49 | 1.35 | 1.38 |
| Fixed Asset Turnover | 1.27 | 1.51 | 1.70 | 1.49 | 1.40 |
| Asset Turnover | 0.36 | 0.38 | 0.37 | 0.31 | 0.25 |
| Working Capital Turnover Ratio | 0.92 | 0.92 | 0.87 | 0.67 | 0.53 |
| Cash Conversion Cycle | 260.53 | 243.21 | 266.73 | 306.83 | 307.88 |
| Days of Sales Outstanding | 41.12 | 50.31 | 46.69 | 67.38 | 78.25 |
| Days of Inventory Outstanding | 252.29 | 220.86 | 245.78 | 269.78 | 264.06 |
| Days of Payables Outstanding | 32.88 | 27.95 | 25.74 | 30.32 | 34.44 |
| Operating Cycle | 293.41 | 271.16 | 292.48 | 337.15 | 342.32 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.70 | 2.78 | 3.72 | 1.33 | 1.94 |
| Free Cash Flow Per Share | 1.92 | 1.21 | 2.15 | -0.49 | 0.40 |
| Dividend Paid and CapEx Coverage Ratio | 1.55 | 1.04 | 1.86 | 0.53 | 0.95 |
| Capital Expenditure Coverage Ratio | 3.45 | 1.77 | 2.37 | 0.73 | 1.26 |
| Operating Cash Flow Coverage Ratio | 1.58 | 1.45 | 1.56 | 1.96 | 3.24 |
| Operating Cash Flow to Sales Ratio | 0.26 | 0.24 | 0.24 | 0.11 | 0.20 |
| Free Cash Flow Yield | 8.76% | 4.85% | 8.73% | -2.13% | 1.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 20.29 | 13.91 | 10.11 | 22.35 | 14.98 |
| Price-to-Sales (P/S) Ratio | 2.08 | 2.18 | 1.60 | 1.92 | 3.02 |
| Price-to-Book (P/B) Ratio | 0.94 | 1.05 | 0.74 | 0.73 | 0.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.41 | 20.61 | 11.45 | -46.98 | 75.18 |
| Price-to-Operating Cash Flow Ratio | 8.10 | 9.00 | 6.63 | 17.44 | 15.42 |
| Price-to-Earnings Growth (PEG) Ratio | -0.51 | -0.53 | 0.08 | -0.47 | 0.28 |
| Enterprise Value Multiple | 6.83 | 6.65 | 2.63 | 3.60 | 4.51 |
| Enterprise Value | 3.04B | 3.65B | 1.87B | 1.61B | 2.48B |
| EV to EBITDA | 6.83 | 6.65 | 2.63 | 3.60 | 4.51 |
| EV to Sales | 1.24 | 1.36 | 0.71 | 0.77 | 1.42 |
| EV to Free Cash Flow | 6.82 | 12.91 | 5.10 | -18.75 | 35.36 |
| EV to Operating Cash Flow | 4.84 | 5.63 | 2.95 | 6.96 | 7.25 |
| Tangible Book Value Per Share | 21.22 | 20.54 | 28.55 | 27.13 | 27.65 |
| Shareholders’ Equity Per Share | 23.34 | 23.92 | 33.09 | 31.78 | 32.44 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | 0.19 | 0.19 | 0.19 | 0.09 |
| Revenue Per Share | 10.53 | 11.50 | 15.43 | 12.12 | 9.94 |
| Net Income Per Share | 1.05 | 1.80 | 2.44 | 1.04 | 2.00 |
| Tax Burden | 1.02 | 0.90 | 0.82 | 0.77 | 0.92 |
| Interest Burden | 1.00 | 1.25 | 0.99 | 0.97 | 0.99 |
| Research & Development to Revenue | 0.09 | 0.10 | 0.08 | 0.09 | 0.10 |
| SG&A to Revenue | 0.51 | 0.46 | 0.16 | 0.19 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Income Quality | 2.57 | 1.39 | 1.25 | 0.98 | 0.89 |
Currency in CNY

